Posted in | News | Optics and Photonics

Skorpios to Demonstrate 100G QSFP28 Transceiver at OFC

Skorpios Technologies, Inc., a fabless integrated silicon photonics system on a chip company, today announced the demonstration of a 100G QSFP28 transceiver utilizing Skorpios' Template Assisted Bonding (STAB) process.

In this product, the lasers, modulators, detectors and optical multiplexer/de-multiplexer are monolithically integrated into a single die using the STAB process, providing customers with cost, size and power benefits unachievable with any alternative technologies.

"We are delighted to be demonstrating our QSFP28 at OFC this year," stated Alfredo Viglienzoni, SVP Sales, Marketing and Business Development. "With our unique integration approach, we can build solutions such as this product, which meet the increasing challenges of bandwidth growth within data centers. This is particularly attractive for those customers who have to operate within fixed infrastructure constraints to minimize capex."

"The Skorpios QSFP28 underscores our ability to integrate higher level module solutions based on our STAB process. It operates without active cooling, and has a reach of up to 10km, making it ideal for the mega-scale architectures which are emerging to support cutting edge services," commented Glenn Li, VP Engineering, Enterprise. "This product represents our first step towards multi-Tb/s interconnect bandwidth with small footprint, low power consumption, and low cost. Our high-speed WDM solutions enable bandwidth increase by better utilizing and without altering the existing cabling structure, thus offering a low- barrier, future-proof upgrade path."

Skorpios invites customers to meet at the Optical Fiber Communications Conference (OFC) in San Francisco, March 9 – 13th, 2013. Please contact John Trainor (+44-118-973-3444) or Alfredo Viglienzoni (+1-323-823-9760) to arrange further discussions, and schedule a demonstration.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.